The Beaten-Down Stock Wall Street Insiders Are Quietly Loading Up On

The smart money on Mission Produce (NASDAQ: AVO) is unambiguously bullish, and the signal is coming from inside the boardroom. Two directors stepped into the open market in the days after a brutal Q2 FY2026 earnings miss, and sell-side analysts covering the name are uniformly positive with price targets well above the current quote.

The conviction shows up across three independent data points. First, the analyst panel tracked by Alpha Vantage assigns Mission Produce four Buy ratings and no Holds or Sells, with a consensus price target of $16.50 against a current price of $11.71 as of June 23, 2026. Freedom Broker analyst Balzhan Tleuzhanova raised the price target from $15.00 to $16.00 on June 10, 2026, maintaining a Buy rating following the report.

Second, the open-market insider buying is concentrated, large, and timed to the post-earnings drawdown. Director Bruce C. Taylor purchased 155,842 shares at $11.16 and 10,000 shares at $11.14 on June 12, 300,000 shares at $11.29 on June 15, and 13,590 shares at $11.40 on June 16. Director Jay A. Pack bought 25,281 shares at $11.03 and 12,169 shares at $11.04 on June 11, then 77,831 and 110,719 shares at $11.34 on June 15. Combined, the two directors deployed capital across eight separate purchases over a six-day window totaling 705,432 shares. Compare that to CEO John Pawlowski’s prior disposition of 7,286 shares at $14.44 on April 5, 2026: insiders sold higher and are now buying lower.

Third, the price action confirms the market has begun to credit the recovery thesis. From the filing-day close of $10.11 on June 8, the stock has run 15.83% to $11.71 through June 23, while the broader market drifted lower over the same window.

The Gap Between Wall Street and the Stock

The headline disconnect is striking. As mentioned, Mission Produce trades at $11.71 against a sell-side target of $16.50, though media coverage cites a broader $15 to $18 analyst range. The 50-day and 200-day moving averages are $11.27 and $11.90, respectively, meaning the stock is still trading below trend despite the bounce.

What insiders see that the stock has not yet priced: management guided H2 FY2026 consolidated adjusted EBITDA of $84 million to $88 million and is targeting at least $25 million in annual synergies from the Calavo acquisition that closed May 28, 2026. CEO John Pawlowski stated on the call that “supply conditions have improved, pricing and margins are recovering, and we expect to deliver solid performance in the back half of the year.” The board backed that view by authorizing a new $100 million share repurchase program on June 3, 2026, running 36 months.

For a retail investor weighing the position today, the gap matters because the catalyst calendar is concrete: a Q3 print with partial Calavo contribution, a planned fall 2026 Investor Day, and synergy realization beginning Q4 FY2026.

Is the Smart Money Right?

The bull case has three things institutional and insider buyers rarely get simultaneously: a quantifiable miss already in the price, explicit forward guidance that frames a recovery, and directors putting personal capital to work near 52-week lows of $10.07.

The risks are concrete. Mission Produce carries $350 million in term-loan debt post-Calavo, faces integration execution risk, and remains exposed to avocado price volatility that just produced a 36% per-pound price decline year over year. The forward P/E of 23x assumes the H2 EBITDA bridge holds. Director buying is one signal, not a guarantee, and the stock remains small and illiquid relative to large-cap consumer staples. The smart money has staked out its position. Retail investors weighing exposure should size their positions according to that risk profile.